Aflac (AFL) Projected to Post Quarterly Earnings on Wednesday

Aflac (NYSE:AFL) is anticipated to issue its Q4 2025 Pre Recorded results after the market closes on Wednesday, February 4th. Analysts expect the company to announce earnings of $1.72 per share and revenue of $4.4543 billion for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 Pre Recorded earning report for the latest details on the call scheduled for Wednesday, February 4, 2026 at 8:00 AM ET.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Tuesday, November 4th. The financial services provider reported $2.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.77 by $0.72. Aflac had a return on equity of 14.97% and a net margin of 23.55%.The business had revenue of $4.41 billion during the quarter, compared to analysts’ expectations of $4.36 billion. During the same period in the previous year, the firm posted $2.16 earnings per share. The company’s revenue was up 59.4% on a year-over-year basis. On average, analysts expect Aflac to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Aflac Price Performance

Shares of NYSE AFL opened at $108.39 on Wednesday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.11 and a current ratio of 0.11. Aflac has a fifty-two week low of $96.95 and a fifty-two week high of $115.83. The stock’s 50-day simple moving average is $109.76 and its 200-day simple moving average is $108.12. The firm has a market capitalization of $56.81 billion, a PE ratio of 14.15, a price-to-earnings-growth ratio of 3.22 and a beta of 0.67.

Aflac Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Wednesday, February 18th will be given a dividend of $0.61 per share. This represents a $2.44 dividend on an annualized basis and a yield of 2.3%. This is an increase from Aflac’s previous quarterly dividend of $0.58. The ex-dividend date is Wednesday, February 18th. Aflac’s dividend payout ratio (DPR) is 30.29%.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. JPMorgan Chase & Co. increased their price target on Aflac from $101.00 to $105.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Evercore ISI increased their price target on Aflac from $110.00 to $111.00 and gave the company an “underperform” rating in a research report on Friday, November 7th. Weiss Ratings reissued a “buy (b+)” rating on shares of Aflac in a research report on Monday, December 22nd. Mizuho began coverage on shares of Aflac in a research report on Tuesday, December 16th. They set an “underperform” rating and a $104.00 target price for the company. Finally, TD Cowen reaffirmed a “hold” rating on shares of Aflac in a report on Monday, December 22nd. Three investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $110.64.

Insider Buying and Selling at Aflac

In related news, EVP Audrey B. Tillman sold 15,862 shares of the stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $112.00, for a total transaction of $1,776,544.00. Following the completion of the transaction, the executive vice president owned 230,688 shares in the company, valued at approximately $25,837,056. This represents a 6.43% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Frederic Jean Guy Simard sold 1,722 shares of the stock in a transaction dated Thursday, November 6th. The stock was sold at an average price of $112.50, for a total transaction of $193,725.00. Following the completion of the sale, the executive vice president directly owned 1,364 shares in the company, valued at approximately $153,450. The trade was a 55.80% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 31,766 shares of company stock worth $3,549,706. Company insiders own 0.80% of the company’s stock.

Institutional Investors Weigh In On Aflac

Institutional investors and hedge funds have recently modified their holdings of the stock. Keel Point LLC grew its stake in shares of Aflac by 1.3% in the second quarter. Keel Point LLC now owns 8,489 shares of the financial services provider’s stock worth $895,000 after acquiring an additional 107 shares during the last quarter. Lazard Asset Management LLC lifted its position in shares of Aflac by 6.2% in the second quarter. Lazard Asset Management LLC now owns 1,942 shares of the financial services provider’s stock valued at $203,000 after acquiring an additional 113 shares in the last quarter. Bison Wealth LLC increased its holdings in Aflac by 4.3% in the 4th quarter. Bison Wealth LLC now owns 4,402 shares of the financial services provider’s stock valued at $455,000 after acquiring an additional 183 shares during the last quarter. Main Street Financial Solutions LLC raised its holdings in shares of Aflac by 1.6% during the 2nd quarter. Main Street Financial Solutions LLC now owns 11,953 shares of the financial services provider’s stock worth $1,261,000 after acquiring an additional 192 shares in the last quarter. Finally, Gould Capital LLC grew its position in Aflac by 0.6% in the third quarter. Gould Capital LLC now owns 29,815 shares of the financial services provider’s stock worth $3,330,000 after acquiring an additional 192 shares in the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Aflac Company Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.